143 related articles for article (PubMed ID: 817293)
1. Development and chimpanzee testing of a vaccine against human hepatitis B.
Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
Proc Soc Exp Biol Med; 1976 Apr; 151(4):694-700. PubMed ID: 817293
[TBL] [Abstract][Full Text] [Related]
2. Vaccine against human hepatitis B.
Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
JAMA; 1976 Jun; 235(26):2832-4. PubMed ID: 819667
[TBL] [Abstract][Full Text] [Related]
3. Successful postexposure vaccination against hepatitis B in chimpanzees.
Iwarson S; Wahl M; Ruttimann E; Snoy P; Seto B; Gerety RJ
J Med Virol; 1988 Aug; 25(4):433-9. PubMed ID: 3171558
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles.
Tabor E; Howard CR; Skelly J; Snoy P; Goudeau A; Zuckerman AJ; Gerety RJ
J Med Virol; 1982; 10(1):65-74. PubMed ID: 7130967
[TBL] [Abstract][Full Text] [Related]
5. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T
J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148
[TBL] [Abstract][Full Text] [Related]
7. Failure to detect infectious hepatitis B virus using high dose safety test for hepatitis B vaccine.
Tabor E; Barker LF; Gerety RJ
J Med Virol; 1981; 6(4):279-84. PubMed ID: 7241095
[TBL] [Abstract][Full Text] [Related]
8. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
[TBL] [Abstract][Full Text] [Related]
9. Immunization of chimpanzees with hepatitis B virus-derived polypeptides.
Dreesman GR; Hollinger FB; Sanchez Y; Oefinger P; Melnick JL
Infect Immun; 1981 Apr; 32(1):62-7. PubMed ID: 7216495
[TBL] [Abstract][Full Text] [Related]
10. [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].
Stamm B; Gerlich W; Thomssen R
Med Microbiol Immunol; 1979 May; 167(2):83-97. PubMed ID: 572908
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).
Fujisawa Y; Kuroda S; Van Eerd PM; Schellekens H; Kakinuma A
Vaccine; 1990 Jun; 8(3):192-8. PubMed ID: 2363298
[TBL] [Abstract][Full Text] [Related]
12. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
Schellekens H; de Reus A; Peetermans JH; van Eerd PA
Postgrad Med J; 1987; 63 Suppl 2():93-6. PubMed ID: 3317363
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.
Davis HL; McCluskie MJ; Gerin JL; Purcell RH
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7213-8. PubMed ID: 8692971
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
[TBL] [Abstract][Full Text] [Related]
15. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
Szmuness W; Stevens CE; Zang EA; Harley EJ; Kellner A
Hepatology; 1981; 1(5):377-85. PubMed ID: 7030902
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A
J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ
J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.
Purcell RH; Gerin JL
Am J Med Sci; 1975; 270(2):395-9. PubMed ID: 828832
[TBL] [Abstract][Full Text] [Related]
19. Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture.
McAleer WJ; Markus HZ; Wampler DE; Buynak EB; Miller WJ; Weibel RE; McLean AA; Hilleman MR
Proc Soc Exp Biol Med; 1984 Mar; 175(3):314-9. PubMed ID: 6320212
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein.
Emini EA; Larson V; Eichberg J; Conard P; Garsky VM; Lee DR; Ellis RW; Miller WJ; Anderson CA; Gerety RJ
J Med Virol; 1989 May; 28(1):7-12. PubMed ID: 2723618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
